Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193805-25-000731
Filing Date
2025-05-28
Accepted
2025-05-28 16:57:03
Documents
5

Document Format Files

Seq Description Document Type Size
1 e664548_424b5-immunic.htm 424B5 470221
2 GRAPHIC image_001.jpg GRAPHIC 7267
3 GRAPHIC image_003.jpg GRAPHIC 7267
4 GRAPHIC image_002.jpg GRAPHIC 134369
5 GRAPHIC image_004.jpg GRAPHIC 43700
  Complete submission text file 0001193805-25-000731.txt   737043
Mailing Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036
Business Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036 (332) 255-9818
IMMUNIC, INC. (Filer) CIK: 0001280776 (see all company filings)

EIN.: 562358443 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-275717 | Film No.: 25996155
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)